Gastrointestinal Microbiome Modulators (N/A)

Gastrointestinal microbiome modulators are agents or interventions designed to intentionally alter the composition, diversity, or function of the gut microbiota to restore or optimize gut microbial balance, with implications for health and disease management. These include probiotics, prebiotics, synbiotics, novel biotics, dietary changes, fecal microbiota transplantation, and targeted antimicrobial therapies. Microbial metabolites such as SCFAs interact with host receptors influencing metabolic pathways and immune responses. Modulation strategies are being explored for various disorders but face challenges regarding safety, efficacy standardization, and long-term effects.

Other names

Gut Microbiota ModulatorsMicrobiome TherapeuticsGut Flora Modifiers

Varies depending on the specific modulator; includes altering microbial composition, stimulating beneficial microbial activity, direct interaction of microbial metabolites with host receptors (GPR41/43/119, PPARα/γ, AhR), and modulation of immune responses.